Edition:
United States

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

4.87USD
4:00pm EDT
Change (% chg)

$0.03 (+0.62%)
Prev Close
$4.84
Open
$4.99
Day's High
$4.99
Day's Low
$4.77
Volume
22,458
Avg. Vol
24,019
52-wk High
$8.61
52-wk Low
$3.13

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.339
Mar '18 0.00 -0.362
FY 2017 Dec '17 0.00 -0.294
Sep '17 0.00 -0.428
Jun '17 0.00 -1.603
Mar '17 0.00 -0.428
FY 2016 Dec '16 0.00 -1.485
Sep '16 0.00 -3.686
Jun '16 0.00 -5.378
Mar '16 0.00 -4.545
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 2 -0.40 -0.38 -0.42 --
Quarter Ending Dec-18 2 -0.32 -0.22 -0.42 --
Year Ending Dec-18 2 -1.38 -1.22 -1.54 --
Year Ending Dec-19 2 -1.37 -1.14 -1.59 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.43 32.65
P/E High - Last 5 Yrs. -- 42.05 47.28
P/E Low - Last 5 Yrs. -- 23.55 24.79
Beta 0.34 0.89 0.87
Price to Sales (TTM) -- 4.40 6.44
Price to Book (MRQ) 2.12 3.53 3.90
Price to Tangible Book (MRQ) 2.33 5.08 5.95
Price to Cash Flow (TTM) -- 22.46 23.45
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.83 1.70
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.55 -5.68
Payout Ratio(TTM) -- 49.33 46.50

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.62 8.40
Sales (TTM) vs TTM 1 Yr. Ago -- 4.61 6.69
Sales - 5 Yr. Growth Rate -- 6.94 7.57
EPS (MRQ) vs Qtr. 1 Yr. Ago 78.86 18.86 25.61
EPS (TTM) vs TTM 1 Yr. Ago 80.24 -- --
EPS - 5 Yr. Growth Rate -- 6.48 7.61
Capital Spending - 5 Yr. Growth Rate -- 7.83 8.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.19 2.20
Current Ratio (MRQ) 14.52 2.93 2.97
LT Debt to Equity (MRQ) 0.00 8.92 11.19
Total Debt to Equity (MRQ) 0.00 11.20 14.01
Interest Coverage (TTM) -- 41.11 35.20

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.10 54.65
Gross Margin - 5 Yr. Avg. -- 53.32 53.29
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.73 15.94
Operating Margin (TTM) -- 13.30 3.76
Operating Margin - 5 Yr. Avg. -- 14.32 11.06
Pre-Tax Margin (TTM) -- 13.68 4.08
Pre-Tax Margin - 5 Yr. Avg. -- 14.62 11.25
Net Profit Margin (TTM) -- 10.30 0.80
Net Profit Margin - 5 Yr. Avg. -- 10.91 7.58
Effective Tax Rate (TTM) -- 20.47 20.44
Effective Tax Rate - 5 Yr. Avg. -- 23.81 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 820,032,733 714,438,801
Net Income/Employee (TTM) -- 94,806,459 82,488,037
Receivable Turnover (TTM) -- 5.00 5.03
Inventory Turnover (TTM) -- 2.52 3.60
Asset Turnover (TTM) 0.00 0.83 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.47 9.99 9.74
Return on Assets - 5 Yr. Avg. -53.18 11.38 10.91
Return on Investment (TTM) -49.01 13.04 12.72
Return on Investment - 5 Yr. Avg. -57.03 14.69 14.03
Return on Equity (TTM) -49.27 14.97 14.84
Return on Equity - 5 Yr. Avg. -106.86 15.90 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 81.42 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novus Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.76%
# of Holders: 29
Total Shares Held: 4,970,874
3 Mo. Net Change: -732,630
# New Positions: 4
# Closed Positions: 3
# Increased Positions: 11
# Reduced Positions: 10
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.